The Indonesian Journal of Cancer Control (InaJCC) is a quadrimester electronic journal, publishing papers in a wide spectrum of cancer control. The journal was launched in 2021 as the official publication of The Indonesian Society of Oncology.

Vol. 2 No. 1 (2022): January - April 2022

Published: 2022-04-30

Prognostic value of tumor-infiltrating lymphocytes among HER-2+ breast cancer patients receiving trastuzumab-based adjuvant therapy

dr. Diah Ari Safitri, Sp.PD-KHOM, Dr. dr. Ahmad Ghozali, Sp.PA(K), dr. Johan Kurnianda, Sp.PD-KHOM

2-9

Correlation between chemotherapy cycles and performance status based on ECOG in non-small cell lung cancer patients

NOVITA ANDAYANI, Diana F Syafni, Mirfandi Amirsyah, Yunita Arliny, Rima Novirianthy, Murtaza

10-15

A rare case of falcotentorial meningioma type II of the pineal region

Rahmad Mulyadi, Prijo Sidipratomo, Taufik Budianto, Eka Susanto

16-20

Palliative management of advanced stage head and neck cancer

Evidence-based case report

Marlinda Adham , Anita Amalia Sari, Rudi Putranto, Indrati Suroyo, Eka Dian Safitri

21-31

View All Issues

Edisi Januari-April 2022:

  1. Palliative management in advance stage of head and neck cancer. Evidence-based medicine case report.
    Marlinda Adham
  2. Prognostic value of tumor-infiltrating lymphocytes among HER-2+ breast cancer patients receiving trastuzumab-based adjuvant therapy.
    Diah A Safitri
  3. The Indonesian National Guidelines of Clinical Practice for lung cancer: Focus on screening program.
    IASTO (Indonesian Association for the Study on Thoracic Oncology)
  4. Perianal infections in acute leukemia patients who received induction and consolidation chemotherapy: Clinical manifestations, pathogenesis, complications, management, and prevention.
    Diah Pitaloka
  5. Cervical cancer strategy in Indonesia with VIA-DoVIA screening and see and treat.
    Laila Nuranna
  6. An observational study: Thoracic malignancies with confirmed COVID-19.
    Elisna Syahruddin
  7. Diagnostic and management of nasopharyngeal carcinoma post-chemoradiation.
    Marlinda Adham